Croda launches Malvallin™ botanical active for skin resilience
- Patent-pending botanical active derived from Chinese mallow fruit and 100% naturally derived according to ISO16128.
- Produced in France and clinically tested: visible improvements in hydration, redness, skin texture and cheek volume after 28 days.
- Designed to act across hypodermis, dermis and epidermis to support firmness, elasticity, hydration and facial volume.
- Certified COSMOS, vegan compliant, RSPO and Halal; positioned for premium, prevention-driven skincare targeting Gen Y and Gen Z demand.
Product overview
Croda’s Malvallin™ is a patent-pending, plant-derived active produced at the company’s site in France. Derived from Chinese mallow fruit and 100% naturally derived under ISO16128, the ingredient is positioned for premium skincare focused on maintaining skin structure and resilience rather than only correcting visible ageing.
Efficacy and evidence
Croda reports biologic, clinical and consumer-perception validation. Clinical testing showed visible improvements in hydration, redness, skin texture and cheek volume after 28 days, and advanced 3D imaging and eye‑tracking studies indicated enhanced perceived facial attractiveness.
Formulation and market positioning
Malvallin is designed to deliver multifunctional efficacy across the hypodermis, dermis and epidermis, enabling streamlined, high-performance formulations. Croda positions the active to meet prevention-driven consumer demand—especially from Gen Y and Gen Z—for long-term skin health and premium product claims.
Sustainability and certification
The ingredient carries COSMOS approval and is vegan compliant, with RSPO and Halal certifications cited to support responsible sourcing and formulation strategies for brand customers.
Source: Croda
